(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS BIESPECÍFICOS QUE ALVEJAM PD1 E VEGF

Em AnáliseInvention PatentPCT · CN2023137517

Application data

Number

112025011174

Type

Invention Patent

Filing

12/08/2023

Publication

03/24/2026

PCT

CN2023137517

Progress at the INPI

Examination not yet requested
  1. Filing12/08/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 12/08/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:12/08/2026(105 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/24/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

LANOVA MEDICINES LIMITED

CN

Inventors

H. G. (pessoa física)

CN

R. L. (pessoa física)

CN

W. C. (pessoa física)

CN

W. H. (pessoa física)

CN

Y. Z. (pessoa física)

CN

Technical data

Priority claims

CN

PCT/CN2022/138363 · 12/12/2022

Abstract

ANTICORPOS BIESPECÍFICOS QUE ALVEJAM PD1 E VEGF. São fornecidos anticorpos biespecíficos capazes de se ligarem à proteína de VEGF humano e à proteína de PD-1 humana. Esses anticorpos biespecíficos são eficazes no tratamento de câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

03/24/2026

RPI 2881

Alteração de dados cadastrais

#1.1

06/10/2025

RPI 2840

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.